Nomogram for predicting the benefit of neoadjuvant chemoradiotherapy for patients with esophageal cancer: A SEER‐Medicare analysis

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0142|120|4|492-498

ISSN: 0008-543x

Source: CANCER, Vol.120, Iss.4, 2014-02, pp. : 492-498

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract